Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a class of
subgroup-selective 5-hydroxytryptamine (5-HT) agonists.
The aim of this study was to evaluate the efficacy and safety of tegaserod on bowel habits in
male patients with chronic constipation.